Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 24-Oct-2023
No. of pages: 104

Market Overview of Global RNAi for Therapeutic market:

According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years.

RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of gene expression. The notion that RNAi could lead to a new class of therapeutics caught the attention of many investigators soon after its discovery. The field of applied RNAi therapeutics has moved very quickly from lab to bedside. The RNAi approach has been widely used for drug development and several phase I and II clinical trials are under way. However, there are still some concerns and challenges to overcome for therapeutic applications. These include the potential for off-target effects, triggering innate immune responses and most importantly obtaining specific delivery into the cytoplasm of target cells.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global RNAi for Therapeutic market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global RNAi for Therapeutic Market Report:

Market Size Estimates: RNAi for Therapeutic market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: RNAi for Therapeutic market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the RNAi for Therapeutic market

Segment Market Analysis: RNAi for Therapeutic market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: RNAi for Therapeutic market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the RNAi for Therapeutic Market: Revenue and sales volume of major countries in each region

RNAi for Therapeutic Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the RNAi for Therapeutic market in major regions.

RNAi for Therapeutic Industry Value Chain: RNAi for Therapeutic market raw materials & suppliers, manufacturing process, distributors, downstream customers

RNAi for Therapeutic Industry News, Policies & Regulations

Key players in the global RNAi for Therapeutic market are covered in Chapter 12:

miRagen Therapeutics

Silenseed

Dicerna Pharmaceuticals

Quark Pharmaceuticals

Benitec Biopharma

RXi Pharmaceuticals

Alnylam Pharmaceuticals

Silence Therapeutics

Arrowhead

Sylentis

Mirna Therapeutics

Gradalis

Sirnaomics

Arbutus Biopharma (Tekmira)

In Chapter 2 and Chapter 15.1, based on types, the RNAi for Therapeutic market from 2018 to 2028 is primarily split into:

siRNA

miRNA

shRNA

In Chapter 3 and Chapter 15.2, based on applications, the RNAi for Therapeutic market from 2018 to 2028 covers:

Cancer

Cardiovascular

HBV

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the RNAi for Therapeutic market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 RNAi for Therapeutic Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global RNAi for Therapeutic Market Size (2018-2028)
1.3.1 Global RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global RNAi for Therapeutic Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global RNAi for Therapeutic Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global RNAi for Therapeutic Historic Revenue ($) by Type (2018-2023)
2.2 Global RNAi for Therapeutic Historic Sales Volume by Type (2018-2023)
2.3 siRNA Sales and Price (2018-2023)
2.4 miRNA Sales and Price (2018-2023)
2.5 shRNA Sales and Price (2018-2023)

3 Global RNAi for Therapeutic Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global RNAi for Therapeutic Historic Revenue ($) by Application (2018-2023)
3.2 Global RNAi for Therapeutic Historic Sales Volume by Application (2018-2023)
3.3 Cancer Sales, Revenue and Growth Rate (2018-2023)
3.4 Cardiovascular Sales, Revenue and Growth Rate (2018-2023)
3.5 HBV Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for RNAi for Therapeutic Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 RNAi for Therapeutic Industry News
4.7.2 RNAi for Therapeutic Industry Policies

5 Global RNAi for Therapeutic Market Revenue ($) and Sales Volume by Major Regions
5.1 Global RNAi for Therapeutic Sales Volume by Region (2018-2023)
5.2 Global RNAi for Therapeutic Market Revenue ($) by Region (2018-2023)

6 Global RNAi for Therapeutic Import Volume and Export Volume by Major Regions
6.1 Global RNAi for Therapeutic Import Volume by Region (2018-2023)
6.2 Global RNAi for Therapeutic Export Volume by Region (2018-2023)

7 North America RNAi for Therapeutic Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
7.2 North America RNAi for Therapeutic Market Trends Analysis Under Global Inflation
7.3 North America RNAi for Therapeutic Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific RNAi for Therapeutic Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific RNAi for Therapeutic Market Trends Analysis Under Global Inflation
8.3 Asia Pacific RNAi for Therapeutic Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia RNAi for Therapeutic Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)

9 Europe RNAi for Therapeutic Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
9.2 Europe RNAi for Therapeutic Market Trends Analysis Under Global Inflation
9.3 Europe RNAi for Therapeutic Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)

10 Latin America RNAi for Therapeutic Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
10.2 Latin America RNAi for Therapeutic Market Trends Analysis Under Global Inflation
10.3 Latin America RNAi for Therapeutic Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa RNAi for Therapeutic Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa RNAi for Therapeutic Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa RNAi for Therapeutic Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global RNAi for Therapeutic Revenue ($) and Market Share of Key Players
12.1.2 Global RNAi for Therapeutic Sales Volume and Market Share of Key Players
12.1.3 Global RNAi for Therapeutic Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 miRagen Therapeutics Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 miRagen Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Silenseed Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Silenseed Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Dicerna Pharmaceuticals Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Dicerna Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Quark Pharmaceuticals Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Quark Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Benitec Biopharma Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Benitec Biopharma Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 RXi Pharmaceuticals Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 RXi Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Alnylam Pharmaceuticals Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Alnylam Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Silence Therapeutics Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Silence Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Arrowhead Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Arrowhead Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 Sylentis Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 Sylentis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 Mirna Therapeutics Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 Mirna Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 Gradalis Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 Gradalis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 Sirnaomics Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 Sirnaomics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.15 Arbutus Biopharma (Tekmira) Market Performance and Business Analysis
12.15.1 Company Profiles
12.15.2 Product Profiles and Application
12.15.3 Arbutus Biopharma (Tekmira) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the RNAi for Therapeutic Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of RNAi for Therapeutic
13.3.3 Raw Material Cost of RNAi for Therapeutic
13.3.4 Labor Cost of RNAi for Therapeutic
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global RNAi for Therapeutic Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global RNAi for Therapeutic Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global RNAi for Therapeutic Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global RNAi for Therapeutic Sales Volume Forecast by Type (2023-2028)
15.2 Global RNAi for Therapeutic Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global RNAi for Therapeutic Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global RNAi for Therapeutic Sales Volume Forecast by Application (2023-2028)
15.3 Global RNAi for Therapeutic Sales Volume Forecast by Region (2023-2028)
15.4 Global RNAi for Therapeutic Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure RNAi for Therapeutic Picture
Table RNAi for Therapeutic Definition
Table Description and Definitions
Figure siRNA Features
Figure miRNA Features
Figure shRNA Features
Table Description and Definitions
Figure Cancer
Figure Cardiovascular
Figure HBV
Figure North America RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2028)
Figure Europe RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2028)
Figure Latin America RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2028)
Figure Global RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2028)
Figure Global RNAi for Therapeutic Sales Volume and Growth Rate (2018-2028)
Table Global RNAi for Therapeutic Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global RNAi for Therapeutic Historic Revenue ($) Share by Type (2018-2023)
Table Global RNAi for Therapeutic Historic Sales Volume by Type (2018-2023)
Table Global RNAi for Therapeutic Historic Sales Volume Share by Type (2018-2023)
Figure Global siRNA Sales and Growth Rate (2018-2023)
Figure Global siRNA Price (2018-2023)
Figure Global miRNA Sales and Growth Rate (2018-2023)
Figure Global miRNA Price (2018-2023)
Figure Global shRNA Sales and Growth Rate (2018-2023)
Figure Global shRNA Price (2018-2023)
Table Global RNAi for Therapeutic Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global RNAi for Therapeutic Historic Revenue ($) Share by Application (2018-2023)
Table Global RNAi for Therapeutic Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global RNAi for Therapeutic Historic Sales Volume Share by Application (2018-2023)
Figure Global Cancer Sales and Growth Rate (2018-2023)
Figure Global Cancer Revenue and Growth Rate (2018-2023)
Figure Global Cardiovascular Sales and Growth Rate (2018-2023)
Figure Global Cardiovascular Revenue and Growth Rate (2018-2023)
Figure Global HBV Sales and Growth Rate (2018-2023)
Figure Global HBV Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for RNAi for Therapeutic Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global RNAi for Therapeutic Sales Volume by Region (2018-2023)
Table Global RNAi for Therapeutic Sales Volume Share by Region (2018-2023)
Table Global RNAi for Therapeutic Market Revenue ($) by Region (2018-2023)
Table Global RNAi for Therapeutic Market Revenue ($) Share by Region (2018-2023)
Table Global RNAi for Therapeutic Import Volume by Region (2018-2023)
Table Global RNAi for Therapeutic Export Volume by Region (2018-2023)
Figure North America RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure North America RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
Table North America RNAi for Therapeutic Market Trends Analysis Under Global Inflation
Table North America RNAi for Therapeutic Revenue ($) by Country (2018-2023)
Table North America RNAi for Therapeutic Sales Volume by Country (2018-2023)
Figure United States RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Canada RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific RNAi for Therapeutic Market Trends Analysis Under Global Inflation
Table Asia Pacific RNAi for Therapeutic Revenue ($) by Country (2018-2023)
Table Asia Pacific RNAi for Therapeutic Sales Volume by Country (2018-2023)
Figure China RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Japan RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure India RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure South Korea RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia RNAi for Therapeutic Revenue ($) by Country (2018-2023)
Figure Australia RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Europe RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Europe RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
Table Europe RNAi for Therapeutic Market Trends Analysis Under Global Inflation
Table Europe RNAi for Therapeutic Revenue ($) by Country (2018-2023)
Table Europe RNAi for Therapeutic Sales Volume by Country (2018-2023)
Figure Germany RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure France RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Italy RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Spain RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Russia RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Poland RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Latin America RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Latin America RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
Table Latin America RNAi for Therapeutic Market Trends Analysis Under Global Inflation
Table Latin America RNAi for Therapeutic Revenue ($) by Country (2018-2023)
Table Latin America RNAi for Therapeutic Sales Volume by Country (2018-2023)
Figure Mexico RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Brazil RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Argentina RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa RNAi for Therapeutic Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa RNAi for Therapeutic Market Trends Analysis Under Global Inflation
Table Middle East and Africa RNAi for Therapeutic Revenue ($) by Country (2018-2023)
Table Middle East and Africa RNAi for Therapeutic Sales Volume by Country (2018-2023)
Figure GCC Countries RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Figure Africa RNAi for Therapeutic Revenue ($) and Growth Rate (2018-2023)
Table Global RNAi for Therapeutic Revenue ($) of Key Players (2018-2023)
Table Global RNAi for Therapeutic Revenue ($) Share of Key Players (2018-2023)
Table Global RNAi for Therapeutic Sales Volume of Key Players (2018-2023)
Table Global RNAi for Therapeutic Sales Volume Share of Key Players (2018-2023)
Table Global RNAi for Therapeutic Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table miRagen Therapeutics Company Profiles
Table Product Profiles and Application
Table miRagen Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure miRagen Therapeutics Production and Growth Rate
Figure miRagen Therapeutics Value ($) Market Share 2018-2023
Table Silenseed Company Profiles
Table Product Profiles and Application
Table Silenseed Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Silenseed Production and Growth Rate
Figure Silenseed Value ($) Market Share 2018-2023
Table Dicerna Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Dicerna Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Dicerna Pharmaceuticals Production and Growth Rate
Figure Dicerna Pharmaceuticals Value ($) Market Share 2018-2023
Table Quark Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Quark Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Quark Pharmaceuticals Production and Growth Rate
Figure Quark Pharmaceuticals Value ($) Market Share 2018-2023
Table Benitec Biopharma Company Profiles
Table Product Profiles and Application
Table Benitec Biopharma Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Benitec Biopharma Production and Growth Rate
Figure Benitec Biopharma Value ($) Market Share 2018-2023
Table RXi Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table RXi Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure RXi Pharmaceuticals Production and Growth Rate
Figure RXi Pharmaceuticals Value ($) Market Share 2018-2023
Table Alnylam Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Alnylam Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Alnylam Pharmaceuticals Production and Growth Rate
Figure Alnylam Pharmaceuticals Value ($) Market Share 2018-2023
Table Silence Therapeutics Company Profiles
Table Product Profiles and Application
Table Silence Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Silence Therapeutics Production and Growth Rate
Figure Silence Therapeutics Value ($) Market Share 2018-2023
Table Arrowhead Company Profiles
Table Product Profiles and Application
Table Arrowhead Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Arrowhead Production and Growth Rate
Figure Arrowhead Value ($) Market Share 2018-2023
Table Sylentis Company Profiles
Table Product Profiles and Application
Table Sylentis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sylentis Production and Growth Rate
Figure Sylentis Value ($) Market Share 2018-2023
Table Mirna Therapeutics Company Profiles
Table Product Profiles and Application
Table Mirna Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Mirna Therapeutics Production and Growth Rate
Figure Mirna Therapeutics Value ($) Market Share 2018-2023
Table Gradalis Company Profiles
Table Product Profiles and Application
Table Gradalis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Gradalis Production and Growth Rate
Figure Gradalis Value ($) Market Share 2018-2023
Table Sirnaomics Company Profiles
Table Product Profiles and Application
Table Sirnaomics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sirnaomics Production and Growth Rate
Figure Sirnaomics Value ($) Market Share 2018-2023
Table Arbutus Biopharma (Tekmira) Company Profiles
Table Product Profiles and Application
Table Arbutus Biopharma (Tekmira) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Arbutus Biopharma (Tekmira) Production and Growth Rate
Figure Arbutus Biopharma (Tekmira) Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of RNAi for Therapeutic
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of RNAi for Therapeutic with Contact Information
Figure Production Process of RNAi for Therapeutic
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Table Major Distributors of RNAi for Therapeutic with Contact Information
Table Major Downstream Buyers of RNAi for Therapeutic with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global RNAi for Therapeutic Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global RNAi for Therapeutic Revenue ($) Share Forecast by Type (2023-2028)
Table Global RNAi for Therapeutic Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global RNAi for Therapeutic Sales Volume Share Forecast by Type (2023-2028)
Table Global RNAi for Therapeutic Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global RNAi for Therapeutic Revenue ($) Share Forecast by Application (2023-2028)
Table Global RNAi for Therapeutic Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global RNAi for Therapeutic Sales Volume Share Forecast by Application (2023-2028)
Table Global RNAi for Therapeutic Sales Volume Forecast by Region (2023-2028)
Table Global RNAi for Therapeutic Sales Volume Share Forecast by Region (2023-2028)
Table Global RNAi for Therapeutic Revenue ($) Forecast by Region (2023-2028)
Table Global RNAi for Therapeutic Revenue ($) Share Forecast by Region (2023-2028)
  • Global Targeted RNA Sequencing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......
  • Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
  • Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94
    According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
  • Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Market Status and Outlook 2023-2028
    Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106
    RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104
    Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs